143 related articles for article (PubMed ID: 32131065)
21. [Exercise capacity in patients with pulmonary sarcoidosis].
Błaut-Jurkowska J; Knap K; Kaźnica-Wiatr M; Żygadło A; Tomkiewicz-Pająk L; Podolec P; Olszowska M
Pol Merkur Lekarski; 2017 Aug; 43(254):61-65. PubMed ID: 28875971
[TBL] [Abstract][Full Text] [Related]
22. Effects of Pulmonary Rehabilitation in Patients with Non-Cystic Fibrosis Bronchiectasis: A Retrospective Analysis of Clinical and Functional Predictors of Efficacy.
Zanini A; Aiello M; Adamo D; Cherubino F; Zampogna E; Sotgiu G; Chetta A; Spanevello A
Respiration; 2015; 89(6):525-33. PubMed ID: 25924686
[TBL] [Abstract][Full Text] [Related]
23. Cardiopulmonary exercise testing variables as predictors of long-term outcome in thoracic sarcoidosis.
Lopes AJ; Menezes SL; Dias CM; Oliveira JF; Mainenti MR; Guimarães FS
Braz J Med Biol Res; 2012 Mar; 45(3):256-63. PubMed ID: 22331135
[TBL] [Abstract][Full Text] [Related]
24. Membrane and capillary blood components of diffusion capacity of the lung for carbon monoxide in pulmonary sarcoidosis: relation to exercise gas exchange.
Lamberto C; Nunes H; Le Toumelin P; Duperron F; Valeyre D; Clerici C
Chest; 2004 Jun; 125(6):2061-8. PubMed ID: 15189922
[TBL] [Abstract][Full Text] [Related]
25. Benefits of pulmonary rehabilitation in patients with COPD and normal exercise capacity.
Lan CC; Chu WH; Yang MC; Lee CH; Wu YK; Wu CP
Respir Care; 2013 Sep; 58(9):1482-8. PubMed ID: 23287013
[TBL] [Abstract][Full Text] [Related]
26. Sarcoidosis: the value of exercise testing.
Medinger AE; Khouri S; Rohatgi PK
Chest; 2001 Jul; 120(1):93-101. PubMed ID: 11451822
[TBL] [Abstract][Full Text] [Related]
27. Predictors of fatigue in sarcoidosis: The value of exercise testing.
Strookappe B; De Vries J; Elfferich M; Kuijpers P; Knevel T; Drent M
Respir Med; 2016 Jul; 116():49-54. PubMed ID: 27296820
[TBL] [Abstract][Full Text] [Related]
28. Influence of repeated maximal exercise testing on biomarkers and fatigue in sarcoidosis.
Braam AW; de Haan SN; Vorselaars AD; Rijkers GT; Grutters JC; van den Elshout FJ; Korenromp IH
Brain Behav Immun; 2013 Oct; 33():57-64. PubMed ID: 23727274
[TBL] [Abstract][Full Text] [Related]
29. Exercise performance and differences in physiological response to pulmonary rehabilitation in severe chronic obstructive pulmonary disease with hyperinflation.
Albuquerque AL; Quaranta M; Chakrabarti B; Aliverti A; Calverley PM
J Bras Pneumol; 2016 Apr; 42(2):121-9. PubMed ID: 27167433
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary rehabilitation in sarcoidosis: A systematic review and meta-analysis.
Alsina-Restoy X; Torres-Castro R; Caballería E; Gimeno-Santos E; Solis-Navarro L; Francesqui J; Hernández-Gonzalez F; Ramos-Casals M; Blanco I; Sellarés J
Respir Med; 2023; 219():107432. PubMed ID: 37858728
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of Pulmonary Rehabilitation After Treatment for Non-Small Cell Lung Cancer Stages I to IIIa: AN OBSERVATIONAL STUDY.
Janssen SM; Abbink JJ; Lindeboom R; Vliet Vlieland TP
J Cardiopulm Rehabil Prev; 2017 Jan; 37(1):65-71. PubMed ID: 28005681
[TBL] [Abstract][Full Text] [Related]
32. Criterion Validity and Responsiveness of the Steep Ramp Test to Evaluate Aerobic Capacity in Survivors of Cancer Participating in a Supervised Exercise Rehabilitation Program.
Weemaes ATR; Beelen M; Bongers BC; Weijenberg MP; Lenssen AF
Arch Phys Med Rehabil; 2021 Nov; 102(11):2150-2156. PubMed ID: 34023324
[TBL] [Abstract][Full Text] [Related]
33. Effect of high-flow nasal therapy during early pulmonary rehabilitation in patients with severe AECOPD: a randomized controlled study.
Tung LF; Shen SY; Shih HH; Chen YT; Yen CT; Ho SC
Respir Res; 2020 Apr; 21(1):84. PubMed ID: 32293463
[TBL] [Abstract][Full Text] [Related]
34. Reduced exercise capacity in systemic sclerosis patients without pulmonary involvement.
de Oliveira NC; dos Santos Sabbag LM; Ueno LM; de Souza RB; Borges CL; de Sá Pinto AL; Lima FR
Scand J Rheumatol; 2007; 36(6):458-61. PubMed ID: 18092268
[TBL] [Abstract][Full Text] [Related]
35. Spirometry, cardiopulmonary exercise testing and the six-minute walk test results in sarcoidosis patients.
Kiani A; Eslaminejad A; Shafeipour M; Razavi F; Seyyedi SR; Sharif-Kashani B; Emami H; Bakhshayesh-Karam M; Abedini A
Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(3):185-194. PubMed ID: 32476953
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary rehabilitation improves cardiovascular response to exercise in COPD.
Ramponi S; Tzani P; Aiello M; Marangio E; Clini E; Chetta A
Respiration; 2013; 86(1):17-24. PubMed ID: 23711671
[TBL] [Abstract][Full Text] [Related]
37. The association between cardiorespiratory fitness and pulmonary diffusing capacity.
Zavorsky GS; Smoliga JM
Respir Physiol Neurobiol; 2017 Jul; 241():28-35. PubMed ID: 28323203
[TBL] [Abstract][Full Text] [Related]
38. Estimated peak functional capacity: an accurate method for assessing change in peak oxygen consumption after cardiac rehabilitation?
Nichols S; Gleadall-Siddall DO; Antony R; Clark AL; Cleland JGF; Carroll S; Ingle L
Clin Physiol Funct Imaging; 2018 Jul; 38(4):681-688. PubMed ID: 28857391
[TBL] [Abstract][Full Text] [Related]
39. Effect of pulmonary rehabilitation on functional exercise capacity and hypoxemia in patients with interstitial lung diseases: a retrospective study.
Fuschillo S; Felice A; Elia A; Martucci M; Gaudiosi C; Vitali D; Maniscalco M
Sarcoidosis Vasc Diffuse Lung Dis; 2018; 35(3):245-251. PubMed ID: 32476909
[No Abstract] [Full Text] [Related]
40. Predictors of response to pulmonary rehabilitation in stable chronic obstructive pulmonary disease patients: A prospective cohort study.
Ragaselvi S; Janmeja AK; Aggarwal D; Sidana A; Sood P
J Postgrad Med; 2019; 65(2):101-106. PubMed ID: 31036780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
